clopidogrel and Neurodegenerative Diseases

clopidogrel has been researched along with Neurodegenerative Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chai, Z; Lin, J; Wang, C; Yi, X; Zhou, Q	1

Trials

1 trial(s) available for clopidogrel and Neurodegenerative Diseases

Article	Year
Aspirin plus clopidogrel may reduce the risk of early neurologic deterioration in ischemic stroke patients carrying CYP2C192 reduced-function alleles. Journal of neurology, 2018, Volume: 265, Issue:10* Topics: Aged; Aspirin; Brain Ischemia; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Heterozygote; Humans; Incidence; Male; Neurodegenerative Diseases; Pharmacogenomic Variants; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Stroke; Ticlopidine	2018

Article

Year

Aspirin plus clopidogrel may reduce the risk of early neurologic deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.

Journal of neurology, 2018, Volume: 265, Issue:10

Topics: Aged; Aspirin; Brain Ischemia; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Heterozygote; Humans; Incidence; Male; Neurodegenerative Diseases; Pharmacogenomic Variants; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Stroke; Ticlopidine

2018